India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India
18/09/2026 04:38
India's Dr Reddy's inks distribution agreement with Takeda for dengue vaccine in India Sept 18 (Reuters) - Dr Reddy's Laboratories REDY.NS said on Friday it signed a deal with Takeda Pharmaceutical Company 4502.T for the promotion and distribution of the Qdenga dengue vaccine in India.
(Reporting by Kashish Tandon in Bengaluru; Editing by Sonia Cheema)
((Kashish.Tandon@thomsonreuters.com; 8800437922;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption